|
| 36285452 | Accuracy of CT perfusion-predicted core in the late window. | Interv Neuroradiol | 2024 |
| 30808653 | European Stroke Organisation (ESO) - European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischemic Stroke. | J Neurointerv Surg | 2023 |
| 37668620 | Blood Pressure Management After Endovascular Therapy for Acute Ischemic Stroke: The BEST-II Randomized Clinical Trial. | JAMA | 2023 |
| 37282372 | Borderzone Infarcts and Recurrent Cerebrovascular Events in Symptomatic Intracranial Arterial Stenosis: A Systematic Review and Meta-Analysis. | J Stroke | 2023 |
| 36972349 | Trends in Disparities in Advanced Neuroimaging Utilization in Acute Stroke: A Population-Based Study. | Stroke | 2023 |
| 37227729 | Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial. | JAMA Netw Open | 2023 |
| 36999410 | Direct Transfer to the Neuroangiography Suite for Patients With Stroke. | Stroke | 2023 |
| 37030126 | Recurrence risk in symptomatic intracranial stenosis treated medically in the real world. | J Stroke Cerebrovasc Dis | 2023 |
| 37356038 | Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial. | Circulation | 2023 |
| 36852687 | Using Epidemiological Data to Inform Clinical Trial Feasibility Assessments: A Case Study. | Stroke | 2023 |
| 36402094 | Borderzone infarction and recurrent stroke in intracranial atherosclerosis. | J Stroke Cerebrovasc Dis | 2023 |
| 36746635 | Changing Trends in Demographics, Risk Factors, and Clinical Features of Patients With Infective Endocarditis-Related Stroke, 2005-2015. | Neurology | 2023 |
| 36907201 | Thrombolysis for acute ischaemic stroke: current status and future perspectives. | Lancet Neurol | 2023 |
| 36533521 | Recruitment in Acute Stroke Trials: Challenges and Potential Solutions. | Stroke | 2023 |
| 36599699 | Disentangling the Association Between Neurologic Deficits, Patient-Reported Impairments, and Quality of Life After Ischemic Stroke. | Neurology | 2023 |
| 36169032 | Blinding of outcome assessors and its association with outcome in a randomized open-label stroke trial. | Int J Stroke | 2023 |
| 34620594 | Small Vessel Disease, a Marker of Brain Health: What the Radiologist Needs to Know. | AJNR Am J Neuroradiol | 2022 |
| 35474180 | Functional status at 30 and 90 days after mild ischaemic stroke. | Stroke Vasc Neurol | 2022 |
| 35862206 | Substance Use and Performance of Toxicology Screens in the Greater Cincinnati Northern Kentucky Stroke Study. | Stroke | 2022 |
| 35657478 | In Search of the Optimal Antithrombotic Regimen for Intracerebral Hemorrhage Survivors with Atrial Fibrillation. | Drugs | 2022 |
| 35810759 | Intravenous thrombolysis before thrombectomy for acute ischaemic stroke. | Lancet | 2022 |
| 36063821 | Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial. | Lancet | 2022 |
| 36123126 | Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study. | Neurology | 2022 |
| 33739214 | International stroke genetics consortium recommendations for studies of genetics of stroke outcome and recovery. | Int J Stroke | 2022 |
| 34954596 | Association Between CT Angiogram Collaterals and CT Perfusion in Delayed Time Windows for Large Vessel Occlusion Ischemic Strokes. | J Stroke Cerebrovasc Dis | 2022 |
| 35012328 | National Institutes of Health Stroke Scale as an Outcome in Stroke Research: Value of ANCOVA Over Analyzing Change From Baseline. | Stroke | 2022 |
| 35040887 | Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial. | JAMA | 2022 |
| 35039524 | Automated grading of enlarged perivascular spaces in clinical imaging data of an acute stroke cohort using an interpretable, 3D deep learning framework. | Sci Rep | 2022 |
| 35143600 | Intra-arterial Thrombolysis to Target Occlusions in Distal Arteries and the Microcirculation. | JAMA | 2022 |
| 35143325 | Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study. | Stroke | 2022 |
| 35115395 | European Stroke Organisation (ESO)-European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion. | J Neurointerv Surg | 2022 |
| 35086361 | Acute Ischemic Stroke, Depressed Left Ventricular Ejection Fraction, and Sinus Rhythm: Prevalence and Practice Patterns. | Stroke | 2022 |
| 35300256 | European Stroke Organisation - European Society for Minimally Invasive Neurological Therapy expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischaemic stroke and anterior circulation large vessel occlusion. | Eur Stroke J | 2022 |
| 35137645 | Regional and national differences in stroke thrombolysis use and disparities in pricing, treatment availability, and coverage. | Int J Stroke | 2022 |
| 34645285 | Frequency and Prognostic Significance of Clinical Fluctuations Before Hospital Arrival in Stroke. | Stroke | 2022 |
| 34427473 | Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial. | Int J Stroke | 2022 |
| 34772799 | Blood Pressure After Endovascular Thrombectomy and Outcomes in Patients With Acute Ischemic Stroke: An Individual Patient Data Meta-analysis. | Neurology | 2022 |
| 32883780 | Blood pressure reduction and outcome after endovascular therapy: a secondary analysis of the BEST study. | J Neurointerv Surg | 2021 |
| 33558440 | Association of asymptomatic hemorrhage after endovascular stroke treatment with outcomes. | J Neurointerv Surg | 2021 |
| 34496619 | Thrombolysis in Mild Stroke: A Comparative Analysis of the PRISMS and MaRISS Studies. | Stroke | 2021 |
| 34671306 | Endovascular Treatment for Acute Stroke Patients With a Pre-stroke Disability: An International Survey. | Front Neurol | 2021 |
| 34785615 | Reflection on the Past, Present, and Future of Thrombolytic Therapy for Acute Ischemic Stroke. | Neurology | 2021 |
| 34427480 | Stroke network performance during the first COVID-19 pandemic stage: A meta-analysis based on stroke network models. | Int J Stroke | 2021 |
| 34544817 | Prestroke Disability and Outcome After Thrombectomy for Emergent Anterior Circulation Large Vessel Occlusion Stroke. | Neurology | 2021 |
| 34746429 | European Stroke Organisation (ESO) standard operating procedure for the preparation and publishing of guidelines. | Eur Stroke J | 2021 |
| 34157865 | Penumbra Consumption Rates Based on Time-to-Maximum Delay and Reperfusion Status: A Post Hoc Analysis of the DEFUSE 3 Trial. | Stroke | 2021 |
| 34320814 | Standardized Nomenclature for Modified Rankin Scale Global Disability Outcomes: Consensus Recommendations From Stroke Therapy Academic Industry Roundtable XI. | Stroke | 2021 |
| 34233464 | Acute Stroke Imaging Research Roadmap IV: Imaging Selection and Outcomes in Acute Stroke Clinical Trials and Practice. | Stroke | 2021 |
| 34000830 | Predicting 90-Day Outcome After Thrombectomy: Baseline-Adjusted 24-Hour NIHSS Is More Powerful Than NIHSS Score Change. | Stroke | 2021 |
| 33947209 | Predictors of Outcomes in Patients With Mild Ischemic Stroke Symptoms: MaRISS. | Stroke | 2021 |